Aspiriant LLC’s Sera Prognostics SERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,472
Closed -$63.1K 293
2023
Q1
$63.1K Hold
16,472
﹤0.01% 271
2022
Q4
$20.8K Hold
16,472
﹤0.01% 278
2022
Q3
$26K Hold
16,472
﹤0.01% 262
2022
Q2
$28K Hold
16,472
﹤0.01% 273
2022
Q1
$62K Buy
+16,472
New +$95.6K ﹤0.01% 271

Other funds holding SERA

Aspiriant LLC's SERA Position: Q2 2023 in Review

Aspiriant LLC sold out of Sera Prognostics (SERA) in Q2 2023, closing a stake of 16,472 shares — an estimated $63.1K sold.

Aspiriant LLC first reported a position in SERA in Q1 2022 and held it in 5 quarters. The position peaked at $63.1K in Q1 2023. 33 funds tracked by Wall St. Rank hold SERA as of Q2 2023.

  • Aspiriant LLC reported no remaining Sera Prognostics position as of Q2 2023 after selling out during the quarter.
  • Aspiriant LLC sold 16,472 Sera Prognostics shares in Q2 2023, an estimated $63.1K.
  • Aspiriant LLC first reported a position in Sera Prognostics in Q1 2022 and held it in 5 quarters.
  • Aspiriant LLC's Sera Prognostics position peaked at $63.1K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Sera Prognostics as of Q2 2023.

Based on Aspiriant LLC's 13F filing for Q2 2023, filed 19 Jul 2023.